| Product Code: ETC066988 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Non-Oncology Precision Medicine Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 United Kingdom (UK) Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 United Kingdom (UK) Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-oncology diseases in the UK |
4.2.2 Growing adoption of precision medicine technologies and personalized treatment approaches |
4.2.3 Government initiatives and funding to promote precision medicine research and development |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine testing and treatments |
4.3.2 Limited availability and accessibility of precision medicine services in certain regions of the UK |
4.3.3 Regulatory challenges and uncertainties related to the approval and reimbursement of precision medicine therapies |
5 United Kingdom (UK) Non-Oncology Precision Medicine Market Trends |
6 United Kingdom (UK) Non-Oncology Precision Medicine Market, By Types |
6.1 United Kingdom (UK) Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F |
6.1.3 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F |
6.1.4 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F |
6.1.5 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F |
6.1.6 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.1.7 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 United Kingdom (UK) Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F |
6.2.3 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F |
6.2.4 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F |
7 United Kingdom (UK) Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Imports from Major Countries |
8 United Kingdom (UK) Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Average time for diagnosis and treatment initiation in non-oncology precision medicine |
8.2 Number of clinical trials and research studies focused on non-oncology precision medicine in the UK |
8.3 Patient satisfaction scores with personalized treatment plans and outcomes achieved through precision medicine applications. |
9 United Kingdom (UK) Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 United Kingdom (UK) Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 United Kingdom (UK) Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2021 |
10.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here